RecruitingNot ApplicableNCT05838638

Serious Gaming for Chemotherapy-induced Nausea and Vomiting

Serious Gaming for Chemotherapy-induced Nausea and Vomiting in Older Adults With Cancer: A Randomized Clinical Trial


Sponsor

University of Central Florida

Enrollment

610 participants

Start Date

Jun 9, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to examine the effectiveness of a technology-based intervention for managing nausea and vomiting in older adults with cancer. Participants will be randomized to either an intervention or control group. Outcomes such as symptom severity, quality of life, and resource use will be examined.


Eligibility

Min Age: 60 Years

Inclusion Criteria6

  • age 60 or older
  • newly diagnosed with cancer
  • treatment with any chemotherapeutic agent of moderate or high emetic potential
  • on a 2, 3 or 4 week treatment cycle
  • proficient in English
  • has a telephone

Exclusion Criteria3

  • previous diagnosis and/or treatment for cancer
  • end stage disease with less than 6 months to live
  • visually or hearing impaired without corrective device

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALeSSET-CINV

Participants in the intervention group will be asked to play the serious game on an iPad at their first chemotherapy treatment visit. The control group will be able to play at time 6.


Locations(2)

Miller School of Medicine Sylvester Comp. Cancer Center

Miami, Florida, United States

Orlando Health

Orlando, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05838638


Related Trials